Susquehanna International Group’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Susquehanna International Group’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,626	Closed	-$791	–	13398
2023 Q2	$791	Buy	31,626 +6,333	+25%	+$277	﹤0.01%	11911
2023 Q1	$1.52K	Sell	25,293 -122,644	-83%	-$10.4K	﹤0.01%	12393
2022 Q4	$3.71K	Sell	147,937 -15,498	-9%	-$1.24K	﹤0.01%	12084
2022 Q3	$36K	Buy	+163,435	New	+$40.3K	﹤0.01%	12388

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Susquehanna International Group's APGNW Position: Q3 2023 in Review

Susquehanna International Group sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 31,626 shares — an estimated $791 sold.

Susquehanna International Group first reported a position in APGNW in Q3 2022 and held it in 4 quarters. The position peaked at $36K in Q3 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Susquehanna International Group reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Susquehanna International Group sold 31,626 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $791.
Susquehanna International Group first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 4 quarters.
Susquehanna International Group's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $36K in Q3 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.